Effective therapeutic approach for head and neck cancer by an engineered minibody targeting the EGFR receptor.

Although it had relatively short half-life in serum, it was shown to be highly significant anti-tumor effect by inhibiting ERK pathway in A431 xenograft model.

also in 132,142 other papers